New patent expiration for Teva Branded drug SEASONIQUE
Annual Drug Patent Expirations for SEASONIQUE Seasonique is a drug marketed by Teva Branded Pharm and is included in one […]
New patent expiration for Teva Branded drug SEASONIQUE Read Post »
Patent Expiration
New patent expiration for Abbvie drug LINZESS
Annual Drug Patent Expirations for LINZESS Linzess is a drug marketed by Abbvie and is included in one NDA. It
New patent expiration for Myovant Sciences drug MYFEMBREE
Annual Drug Patent Expirations for MYFEMBREE Myfembree is a drug marketed by Myovant Sciences and is included in one NDA.
New patent expiration for Myovant Sciences drug MYFEMBREE Read Post »
New patent expiration for Sumitomo Pharma drug ORGOVYX
Annual Drug Patent Expirations for ORGOVYX Orgovyx is a drug marketed by Sumitomo Pharma and is included in one NDA.
New patent expiration for Sumitomo Pharma drug ORGOVYX Read Post »
New patent expiration for Pf Prism drug TORISEL
Annual Drug Patent Expirations for TORISEL Torisel is a drug marketed by Pf Prism Cv and is included in one
Drug Patent Expirations for the Week of January 21, 2024
EVOCLIN (clindamycin phosphate) Mylan Patent: 7,374,747 Expiration: Jan 23, 2024 See More … For more information on how DrugPatentWatch can
Drug Patent Expirations for the Week of January 21, 2024 Read Post »
New patent expiration for MYLAN drug EVOCLIN
Annual Drug Patent Expirations for EVOCLIN Evoclin is a drug marketed by Mylan and is included in one NDA. There
New patent expiration for Cubist Pharms drug DIFICID
Annual Drug Patent Expirations for DIFICID Dificid is a drug marketed by Cubist Pharms Llc and is included in two
New patent expiration for Cubist Pharms drug DIFICID Read Post »
New patent expiration for Mayne Pharma drug RHOFADE
Annual Drug Patent Expirations for RHOFADE Rhofade is a drug marketed by Mayne Pharma and is included in one NDA.
New patent expiration for Mayne Pharma drug RHOFADE Read Post »
